s 2 Interpretation
2.—(1) In this Act, unless the context otherwise requires —“appropriate consent” has the meaning given by the Human Biomedical Research Act 2015; “clinical trial” means a clinical trial within the meaning of the Medicines Act 1975 or the Health Products Act 2007; “court” means the General Division of the High Court or a Family Court; “deputy” means a person appointed by the court under section 20(2)(b) to make decisions on behalf of another person (“P”) in relation to a matter or matters concerning all or any of the following in respect of which P lacks capacity:(a) P’s personal welfare; (b) P’s property and affairs;[Act 16 of 2021 wef 14/11/2022] “donee” means a person who is conferred authority by a donor (“P”) under a lasting power of attorney to make decisions about all or any of the following when P no longer has capacity to make such decisions:(a) P’s personal welfare, or matters concerning P’s personal welfare that are specified in the lasting power of attorney; (b) P’s property and affairs, or matters concerning P’s property and affairs that are specified in the lasting power of attorney;[Act 16 of 2021 wef 14/11/2022] “donor” means a person (“P”) who confers authority on a donee (or donees) under a lasting power of attorney to make decisions about all or any of the following when P no longer has capacity to make those decisions:(a) P’s personal welfare, or matters concerning P’s personal welfare that are specified in the lasting power of attorney; (b) P’s property and affairs, or matters concerning P’s property and affairs that are specified in the lasting power of attorney;[Act 16 of 2021 wef 14/11/2022] “electronic”, “electronic record”, “record”, “secure electronic signature”, “signed” and “signature” have the meanings given by section 2(1) of the Electronic Transactions Act 2010*;[Act 16 of 2021 wef 14/11/2022] “electronic instrument” means an electronic record that confers authority of the kind mentioned in section 11(1);[Act 16 of 2021 wef 14/11/2022] “electronic transaction system” means the electronic transaction system established by the Public Guardian under section 10B(1);[Act 16 of 2021 wef 14/11/2022] “lasting power of attorney” has the meaning given by section 11; “life-sustaining treatment”, in relation to a person, means treatment which, in the view of another person providing health care for that person, is necessary to sustain life; “non-electronic lasting power of attorney” means a lasting power of attorney that is created using non-electronic means;[Act 16 of 2021 wef 14/11/2022] “professional deputy” means a person —(a) who offers or provides the services of a deputy for remuneration; and (b) who is registered with the Public Guardian as a professional deputy; “professional donee” means a person —(a) who is a professional deputy or is within a class of persons prescribed as qualified to be a professional donee; and (b) who offers or provides the services of a donee for remuneration; “property” includes any thing in action and any interest in real or personal property; “Public Guardian” means the Public Guardian appointed under section 30(1) and, unless the context otherwise requires, includes any Assistant Public Guardian appointed under section 30(1A); “registered medical practitioner” means any person who is registered as a medical practitioner under the Medical Registration Act 1997; “Singapore public sector agency” has the meaning given by section 2(1) of the Public Sector (Governance) Act 2018;[Act 16 of 2021 wef 01/04/2023] “treatment” includes a diagnostic or other procedure; “will” includes codicil.[*Updated to be consistent with the 2020 Revised Edition] [27/2014; 29/2015; 10/2016; 40/2019] (2) In this Act, references to making decisions, in relation to a donee of a lasting power of attorney or a deputy appointed by the court, include, where appropriate, acting on decisions made. (3) For the purposes of this Act, a reference to an instrument that confers authority of the kind mentioned in section 11(1) includes an electronic instrument made in accordance with section 11(2)(b)(ii).[Act 16 of 2021 wef 14/11/2022]